TALPHERA, INC.
TALPHERA, INC. (TLPH): 2 pipeline candidates · ~18 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
17.9 months
D/E 0.63 · 0% dilution
Lead: Phase 3
2 candidates
N/A
5 buys · 0 sells (180d)
A transparent, data-derived signal for TALPHERA, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$45.9M
Cash
$3.8M
Quarterly Burn
$3.4M
Runway
17.9 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
39
Total value held
$5.9M
| Holder | Shares | Value |
|---|---|---|
| rock springs capital management lp | 3,589,186 | $2.7M |
| cantor fitzgerald, l. p. | 887,481 | $663K |
| vanguard capital management llc | 883,222 | $660K |
| dauntless investment group, llc | 435,234 | $325K |
| geode capital management, llc | 419,980 | $314K |
| shay capital llc | 250,083 | $187K |
| renaissance technologies llc | 237,755 | $178K |
| citadel advisors llc | 216,451 | $162K |
| vanguard fiduciary trust co | 192,405 | $144K |
| diadema partners lp | 153,563 | $115K |
Showing top 10 of 39 institutional holders of TALPHERA, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in TALPHERA, INC.'s pipeline?
TALPHERA, INC. (TLPH) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is TALPHERA, INC.'s lead drug candidate?
TALPHERA, INC.'s most advanced tracked candidate is ltx-608 (Preclinical) for Antiviral treatment, or treatment of ARDS, DIC or acute pancreatitis.
What is TALPHERA, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, TALPHERA, INC. has approximately 17.9 months of cash runway.
What is TALPHERA, INC.'s market capitalization?
TALPHERA, INC.'s market capitalization is approximately $45.9M.
Who is the CEO of TALPHERA, INC.?
Mr. Vincent J. Angotti is the chief executive officer of TALPHERA, INC. (TLPH).
Get the full picture on TALPHERA, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.